| Literature DB >> 32264892 |
Kazushi Suzuki1, Rintaro Ohe2, Takanobu Kabasawa1, Naing Ye Aung1, Mitsuhiro Yano3, Shuichiro Katsumi4, Ryo Yanagiya5, Masakazu Yamamoto5, Tomomi Toubai5, Kenichi Ishizawa5, Mitsunori Yamakawa1.
Abstract
BACKGROUND: Ulcerative colitis (UC) is one of the major types of inflammatory bowel diseases and is associated with a significantly increased risk of not only lymphoproliferative disorders but also lymphomas, of which most cases are related to the long-term usage of immunosuppressants. Here, we demonstrate a very rare case of other iatrogenic immunodeficiency-associated colonic diffuse large B-cell lymphoma (Oii-DLBCL) complicating UC and rectal perforation. In addition, we reviewed the clinicopathological features of previous cases of DLBCL related to UC. CASEEntities:
Mesh:
Substances:
Year: 2020 PMID: 32264892 PMCID: PMC7137478 DOI: 10.1186/s13000-020-00954-8
Source DB: PubMed Journal: Diagn Pathol ISSN: 1746-1596 Impact factor: 2.644
Fig. 1Total proctocolectomy specimen: Diffuse, irregular thickening of the colorectal wall extends from the middle of the transverse colon (red broken lines) to the rectum with a rectal perforation (yellow circular broken line). The image of perforation department is shown (Inset)
Fig. 2Histological findings of the resected colon: a The resected colon is transmurally infiltrated by lymphoid cells, and the existing structure is indistinct. b Atypical polymorphous cells diffusely proliferate. c A few Hodgkin-like cells with an eosinophilic nucleolus in the center of a large nucleus are present. d A crypt abscess surrounded by mixed inflammatory cell infiltrates is present in the lamina propria mucosae remote from the lymphoma, compatible with the findings of UC
Fig. 3Immunophenotypic findings of the resected colon: Large, atypical polymorphous lymphoid cells are positive for CD20 by immunohistochemistry (a), positive for the κ-light chain (b) and negative for λ-light chain (c) by in situ hybridization (ISH). Hodgkin-like cells are positive for CD30 by immunohistochemistry (d) and Epstein-Barr encoding region (EBER)-1 (e, Arrowhead) by ISH. Some large, atypical lymphoid cells also are positive for EBER-1 (e) by ISH. In a retrospective analysis, EBER-1-positive large atypical cells are present on the 9-day and 3-week colorectal tissue sections (f & g)
Clinicopathological data of diffuse large B-cell lymphoma (DLBCL) complicating ulcerative colitis published in English literature from 2001 to 2019
| Authors, year | Age/Sex | Ulcerative colitis | Immunosuppressant treatment | Iatrogenic immunodeficiency-associated lymphoproliferative disorders | Outcome | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Site | Duration (month) | Immuno-suppressant | Duration (month) | Type | Site | Mass | EBV | perforation | |||
| Tan, et al., 2001 [ | 36/M | Left-side | 84 | AZA | 32 | DLBCL | Rectum | + | N/A | N/A | Dead (due to renal insufficiency by the disease progression) |
| Khan, et al., 2001 [ | 55/M | Pancolic | 300 | None | None | LCL, B-cell lineage | Rectum | N/A | N/A | N/A | Remission |
| Watanabe, et al., 2003 [ | 42/F | Left-side | 120 | None | None | DLBCL | Colon | + | N/A | N/A | Dead (due to MRSA pneumonia after the transplant) |
| Schwartz, et al., 2006 [ | 29/M | Pancolic | 48 | 6MP, IFX, CYA | 24 | DLBCL | Ileal pouch | + | + | N/A | Remission |
| Shibahara, et al., 2006 [ | 33/M | Pancolic | 108 | AZA, CYA | 48 | DLBCL | Rectum | + | N/A | N/A | Remission |
| Van Hauwaert, et al., 2010 [ | 20/M | N/A | N/A | AZA, IFX | 60 | DLBCL | Rectum | + | – | N/A | N/A |
| Khan, et al., 2012 [ | 59/M | N/A | 132 | None | None | DLBCL | Rectum | + | N/A | + | N/A |
| Allen, et al., 2013 [ | 65/M | Left-side | 60 | AZA, 6MP, IFX | 60 | DLBCL | Colon | + | + | + | N/A |
| Hiyama, et al., 2014 [ | 69/M | Left-side | 42 | AZA | 24 | DLBCL | Rectum | -; Ulcer | + | + | Dead (due to DIC secondary to sepsis) |
| Chang, et al. 2016 [ | 73/M | Pancolic | N/A | MTX | Several years | DLBCL | Colon | + | + | N/A | N/A |
| Our case | 68/M | Pancolic | 26 | AZA, IFX | 6 | DLBCL | Colon | + | + | + | Remission |
M male, F female, AZA azathioprine, 6MP 6-mercaptopurine, IFX infliximab, CYA cyclosporine A, MTX methotrexate, LCL large cell lymphoma, LN lymph node, EBV Epstein-Barr virus, N/A not available, MRSA methicillin-resistant Staphylococcus aureus, DIC disseminated intravascular coagulation syndrome